| Financial Year |
March 31 2023 |
| Monetary Funds |
20,174,416,906.07 |
| Held-for-trading Financial Assets |
1,062,254,207.17 |
| Notes Receivable |
-- |
| Accounts Receivable |
558,288,141.30 |
| Advances to Suppliers |
280,097,756.15 |
| Other Receivables |
587,821,919.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,906,786,627.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
24,190,564.57 |
| Other Current Assets |
180,097,638.48 |
| Total Current Assets |
25,773,953,760.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
56,117,936.97 |
| Long-term Equity Investment |
1,216,477,943.04 |
| Investment Properties |
115,067,801.97 |
| Fixed Assetes |
13,770,596,276.95 |
| Under-construction Projects |
251,167,366.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,348,529,742.01 |
| R&D expenses |
-- |
| Goodwill |
158,971,706.08 |
| Long-Term Deferred and Prepaid Expenses |
952,643,823.29 |
| Deferred Income Tax Assets |
213,033,384.06 |
| Other Non-Current Assets |
881,023.64 |
| Sub-Total of Non-Current Assets |
31,320,478,039.51 |
| Total Assets |
57,094,431,800.50 |
| Short-Term Loans |
595,110,598.06 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,000,000,000.00 |
| Accounts Payable |
5,137,275,252.52 |
| Accounts Received In Advance |
129,311,820.66 |
| Employee Compensation Payable |
453,345,928.24 |
| Taxes Payable |
510,708,554.23 |
| Interest Payable |
-- |
| Dividend Payable |
59,055,885.05 |
| Other payables |
5,643,127,521.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,458,417,282.28 |
| Other Current Liabilities |
3,426,276,592.39 |
| Sub-Total of Current Liabilities |
24,679,746,485.79 |
| Long-term Loans |
2,160,154,703.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
29,326,988.78 |
| Special Payable |
-- |
| Estimatied Liabilities |
135,699,223.73 |
| Deferred Income Tax Liabilities |
810,083,014.60 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,927,200,829.56 |
| Total Liabilities |
36,606,947,315.35 |
| Paid-In Capital(Or Share Stock) |
1,784,168,117.00 |
| Capital Surplus |
3,051,080,458.41 |
| Surplus Reserve |
1,458,997,663.42 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
9,784,566,023.99 |
| Minority Stockholder's Interest |
2,627,358,365.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,860,126,119.76 |
| Owner's Equity（Stockholder's Equity） |
20,487,484,485.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
57,094,431,800.50 |
